Lilly Commits Another $5.3bn To Tirzepatide Supply Expansion Effort

 
• By Joseph Haas
Manufacturing
Lilly is increasing manufacturing spending driven by tirzepatide demand • Source: Shutterstock

More from Manufacturing

More from Business